Skip to main content
OpenTrials
Completed

NCT Number: NCT03877978

Acute Kidney Attack in Severe Traumatized Patients

Acute Kidney Injury (AKI) is a common complication of severe traumatized patients. The diagnosis is often delayed. The Nephrocheck® test allows an earlier assessment of renal stress. The objective of our study is to determine the incidence of risk of AKI in severe traumatized patients within the first 24 hours after their admission to our trauma center. The risk of AKI is defined by a NephroCheck® test >0.3

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Acute Kidney Injury Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Kidney Diseases Male Urogenital Diseases Renal Insufficiency Urogenital Diseases Urologic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hôpital Edouard Herriot

Lyon, 69003, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age >18 years
  • trauma patients with ISS ≥15
  • patient admitted to the resuscitation bay of Edouard Herriot Hospital

Exclusion criteria

  • anuric patient
  • opposition of the patient (or a trusted person) to participate
  • pregnant or lactating woman
  • age <18 years

Treatment and study plan

Nephrocheck test

Biological

Nephrocheck® measurement on urine sample at different timepoints.

Primary outcomes

  1. Incidence of patients with Nephrocheck score > 0,3

    Time frame: Up to 24 hours after trauma

    Incidence of severe traumatized patient at risk of AKI as defined by Nephrocheck test score > 0,3 within the first 24 hours after admission

Sponsors and collaborators

Lead sponsor

Hospices Civils de Lyon

Other

Registry information

Official study title

Evaluation of the Incidence of Acute Kidney Attack by Dosing Nephrocheck® in Severe Traumatized Patients

Acronym: NEPHROTRAUMA

Important dates

Study start
2019
Primary completion
2021
Study completion
2021
First posted
Mar 18, 2019
Registry last updated
May 20, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.